Promethos Capital’s Labcorp LH Stock Holding History

Promethos Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-473	Closed	-$103K	–	78
2024 Q1	$103K	Hold	473	–	–	0.06%	46
2023 Q4	$108K	Buy	+473	New	+$99.4K	0.08%	42

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Promethos Capital's LH Position: Q2 2024 in Review

Promethos Capital sold out of Labcorp (LH) in Q2 2024, closing a stake of 473 shares — an estimated $103K sold.

Promethos Capital first reported a position in LH in Q4 2023 and held it in 2 quarters. The position peaked at $108K in Q4 2023. 854 funds tracked by Wall St. Rank hold LH as of Q2 2024.

Promethos Capital reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
Promethos Capital sold 473 Labcorp shares in Q2 2024, an estimated $103K.
Promethos Capital first reported a position in Labcorp in Q4 2023 and held it in 2 quarters.
Promethos Capital's Labcorp position peaked at $108K in Q4 2023.
854 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Promethos Capital's 13F filing for Q2 2024, filed 12 Aug 2024.